Ketamine for Depression

Ketamine, traditionally an anesthetic, has emerged as a revolutionary treatment for depression, especially treatment-resistant depression. Unlike conventional antidepressants, which can take weeks to show effects, ketamine often produces rapid antidepressant effects within hours. This fast-acting nature makes it a critical option for patients in acute depressive episodes.

Administered in controlled, clinical settings, ketamine works by modulating the brain's glutamate system, promoting synaptic plasticity and neural connectivity. Studies have shown that even low doses can significantly alleviate depressive symptoms, offering relief when other treatments have failed.

Despite its promise, ketamine therapy is not without challenges. The potential for abuse, side effects like dissociation, and the need for repeated administration to maintain benefits are critical considerations. Additionally, long-term safety data is still being accumulated. Nevertheless, ketamine's rapid action and efficacy herald a promising advancement in the treatment of severe depression, providing new hope for those who have exhausted other options.

    Related Conference of Ketamine for Depression

    May 22-23, 2025

    7th European Autism Congress

    Paris, France
    June 16-17, 2025

    10th International Conference on Addiction Therapy

    Zurich, Switzerland
    June 16-17, 2025

    3rd International Conference onPsychiatry and Psychology

    Zurich, Switzerland
    June 16-17, 2025

    35th Euro Congress on Psychiatrists and Psychologists

    Frankfurt, Germany
    June 19-20, 2025

    5th Annual Congress on Mental Health

    Paris, France
    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France

    Ketamine for Depression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in